Ascletis Pharma Inc.

Investors

Financials & Filing

2025

2024

2023

2022

2021

2020

2019

2018

Circulars - Proposals for General Mandates to Issue Shares and Repurchase Shares, Re-Election of Retiring Directors and Notice of Annual General Meeting
2025-04-28
Notification Letter to Non-Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
2025-04-28
Notification Letter to Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications and Reply
2025-04-28
Next Day Disclosure Return - Others
2025-04-25
Next Day Disclosure Return - Others
2025-04-24
Next Day Disclosure Return - Others
2025-04-23
Inside Information - Ascletis Announces Positive Topline Results of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Submission of 13-Week Phase IIa Study Protocol to FDA
2025-04-23
Next Day Disclosure Returns - Share Buyback/Others
2025-04-17
Next Day Disclosure Returns - Share Buyback/Others
2025-04-16
Next Day Disclosure Return - Others
2025-04-15

3

© 2018 Ascletis Pharma Inc. All Rights Reserved
浙公网安备 33010802003344号浙ICP备11050387号-1